Long-Term Liabilities to Equity: TransMedics Group Inc (TMDX)

Official company branding of TransMedics Group, Inc. (TMDX)

Historical price action for TransMedics Group (TMDX) demonstrates a trend where the indicator stands at 1.56. Sales growth is driving the rapid adoption of unique OCS systems. TransMedics Group (TMDX) is transforming transplantation by maintaining organ viability outside the body. Business stability relies on proprietary aviation resources and high-tech US assembly plants, which optimize complex logistics.

TransMedics (TMDX): Long-Term Debt to Capital from 07/04/2022 to 10/28/2026

Comprehensive metric breakdowns and analytics for TransMedics Group Inc (TMDX)

- price and consensus price forecast:
Market Chart TransMedics|TMDX - Price Target Chart
- market capitalization data:
Market Valuation TransMedics Group, Inc.|TMDX - Enterprise Value
- book capitalization data:
Net Asset Value per Share TransMedics|TMDX - Book Capitalization|Market Cap to Net Assets Ratio transmedics.com|TMDX - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient TransMedics Group|TMDX - Long-Term Debt to Capital|Short-Term Debt to Capital TransMedics Corp|TMDX - Company Debts|Debt to Book Capitalization Ratio TransMedics Group, Inc.
Comprehensive company analysis:TMDX, TransMedics Group
Core merchandise of TransMedics Group Inc

This indicator compares credit obligations with a maturity of over one year against equity, reflecting the degree of financial leverage and the company's dependence on external borrowing. Analyzing the long-term debt-to-equity ratio for TransMedics Group (TMDX) allows for an assessment of whether the scaling of high-margin consumables sales is financed through debt or internal funds, thereby eliminating the risk of share dilution during a price decline.

Direct competitors

Ratio of Long-Term Indebtedness to Capital BSX|EW - Long-Term Debt to Equity|Long-Term Liabilities to Equity ResMed Corporation (RMD)|PODD: Long-Term Debt to Capital|Long-Term Liabilities to Capital Zimmer ZBH|COO: Long-Term Debt to Capital|ALGN - Long-Term Debt to Equity Ratio|Globus Medical Corp - Long-Term Debt to Capital|Alphatec Corp (ATEC) - Ratio of Long-Term Indebtedness to Capital|AORT (Artivion, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital ENOV|Long-Term Debt to Equity Integra LifeSciences Holdings Corporation (IART)|Long-Term Debt to Equity Establishment Labs Corp (ESTA)|Long-Term Debt to Capital BBNX|IRMD - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio Embecta Corp.|TNDM - Long-Term Liabilities to Equity|Long-Term Debt to Capital AXGN|SI-BONE Inc (SIBN) - Long-Term Liabilities to Capital|Long-Term Debt to Capital Orthofix International (OFIX)|Long-Term Debt to Capital Ratio Bioventus Global (BVS)|OrthoPediatrics Corp. (KIDS) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient TMCI (treace.com)|Strata Critical Medical - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Carlsmed, Inc. CARL|RXST (RxSight Corp) - Long-Term Debt to Capital|CLPT - Long-Term Liabilities to Capital|Long-Term Debt to Capital Stereotaxis, Inc.|neurostar.com (STIM) - Long-Term Debt to Capital Ratio|SGHT: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Orchestra BioMed Inc.|Long-Term Debt to Capital ANIK (Anika Therapeutics)|Long-Term Debt to Equity Ratio InspireMD Inc. (NSPR)|Long-Term Debt to Capital ZJYL (Jin Medical)|Vivani Medical Inc - Long-Term Debt to Capital|XTNT - Long-Term Debt to Equity|NeuroOne (NMTC) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio modular-medical.com MODD|Myomo Inc (MYO) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital COCH (Envoy Medical, Inc.)|Long-Term Liabilities to Capital VVOS|NVNO: Long-Term Debt to Equity|Long-Term Indebtedness to Equity sintx.com SINT|Long-Term Debt to Equity Ratio TNON (Tenon Medical, Inc)|Long-Term Debt to Capital Lifeward Ltd. LFWD|Long-Term Debt to Capital AMIX (Autonomix)|IVF: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Long-Term Liabilities to Equity|Long-Term Debt to Equity BIOL|Long-Term Debt to Equity Ratio Dynatronics Corp.|Paragon 28, Inc. - Long-Term Debt to Capital|Long-Term Liabilities to Capital INVO (invobioscience.com)